Levilimab Uses, Dosage, Side Effects and more
Levilimab is under investigation in clinical trial NCT04227366 (Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis).
| Trade Name | Levilimab |
| Generic | Levilimab |
| Levilimab Other Names | Levilimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Levilimab works
Levilimab is an IL-6 inhibitor originally developed to treat rheumatoid arthiritis. Its actions at IL-6 help augment cytokine storm effects, reducing inflammation.
